Liver Injury Due to Hormonal Contraceptives in the Modern Era
Liver International · 2026-12 · 46 (12)
DOI: 10.1111/liv.70945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 02.11.2026. Verfasst von Raj Vuppalanchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, USA. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Contraceptives, Oral, Hormonal. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background and Aims Hormonal agents and their association with liver injury remain a concern in clinical practice. This study aimed to characterise the biochemical and clinical features of hormonal agent‐associated liver injury and compare them with a control group of age‐ and gender‐matched cases of liver injury caused by non‐hormonal drugs.
Methods
Of 2123 adjudicated drug‐induced liver injury cases enrolled in the Drug‐Induced Liver Injury Network (2004–2024), 20 high‐confidence cases (1.3%) were attributed to hormonal agents. These cases were compared with age‐ and sex‐matched non‐hormonal drug‐induced liver injury (DILI) controls, and analyses assessed clinical features, biochemical patterns, outcomes, HLA alleles and candidate genetic variants associated with cholestatic liver disease.
Results
The median age of women was 22 years. Most presented within 2–12 weeks with jaundice and pruritus, predominantly with cholestatic or mixed patterns of liver enzyme elevations, but a hepatocellular pattern was not uncommon at 28%. The route of administration did not appear to influence DILI risk. Half underwent a liver biopsy, and half required hospitalization, but none died or required liver transplantation. Compared with other DILI cases, hormonal agent‐associated liver injury was more often cholestatic, with jaundice and pruritus, and less frequently associated with fever or rash. No HLA association was identified, although the intronic MROH2A variant rs6722064 ranked as the top potential candidate for increased risk [OR (95% CI) = 3.58 (1.67, 7.65), p = 0.001].
Conclusions
Hormonal agent‐associated liver injury presents with a distinctive mixed or cholestatic pattern and often lacks the inflammatory features seen in other DILI cases. These findings underscore the need for greater clinical awareness to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, USA.
- UNC Health, Chapel Hill, USA.
- NIH/NIDDK, Bethesda, USA.
- Duke Clinical Research Institute, Durham, USA.
ORCID-Profile: Raj Vuppalanchi, A Sidney Barritt, Huiman Barnhardt, Yi-Ju Li, Naga Chalasani
Förderung
- NIDDK NIH HHS
Zitieren
APA
Vuppalanchi, R., Barritt, A. S., Rai, A., Barnhardt, H., Gu, S., Li, Y. J., Chalasani, N., & Drug‐Induced Liver Injury Network (2026). Liver Injury Due to Hormonal Contraceptives in the Modern Era. Liver International, 46(12). https://doi.org/10.1111/liv.70945
Vancouver
Vuppalanchi R, Barritt AS, Rai A, Barnhardt H, Gu S, Li YJ, et al. Liver Injury Due to Hormonal Contraceptives in the Modern Era. Liver International. 2026;46(12). doi:10.1111/liv.70945
BibTeX
@article{Vuppalanchi2026,
author = {Vuppalanchi, Raj and Barritt, A Sidney and Rai, Anjali and Barnhardt, Huiman and Gu, Sherry and Li, Yi-Ju and Chalasani, Naga and Drug‐Induced Liver Injury Network, Drug‐Induced Liver Injury Network},
title = {Liver Injury Due to Hormonal Contraceptives in the Modern Era},
journal = {Liver International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1111/liv.70945}
}
EUVIMED